LNSR

LENSAR Inc (LNSR)

Healthcare • NASDAQ$5.64+7.84%

Key Fundamentals
Symbol
LNSR
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Price
$5.64
Daily Change
+7.84%
Market Cap
$68.27M
Trailing P/E
N/A
Forward P/E
-7.94
52W High
$14.31
52W Low
$5.06
Analyst Target
$8.50
Dividend Yield
N/A
Beta
0.84
About LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Flori

Company website

Research LNSR on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...